AIDS-related sinonasal Burkitt lymphoma successfully treated with intensive chemotherapy regimen and high active antiretroviral therapy
Hematology, Oncology and Stem Cell Therapy. 2011; 4 (1): 41-44
en En
| IMEMR
| ID: emr-110146
Biblioteca responsable:
EMRO
Burkitt lymphoma [BL] is the second most common AIDS-related lymphoma. Primary sinonasal BL in HIV patients is extremely rare and treatment data in this subset of patients is almost nonexistent. Recently, a few studies reported promising results treating HIV-associate BL with an intensive chemotherapy regimen. The use of highly active antiretroviral therapy [HAART] concomitantly with chemotherapy seems to improve patient outcomes, but this topic is still controversial due to potential drug interactions. We report a case of a 29-year old woman diagnosed with AIDS presenting with symptoms of chronic sinusitis. Subsequent investigation by CT scan and endoscopic biopsy discovered a sinonasal BL in an early stage. The patient was treated with intensive chemotherapy and HAART and achieved a complete remission and long-term immunologic recovery. This case report describes a rare entity whose natural history, treatment and prognosis is infrequently characterized in the medical literature
Buscar en Google
Índice:
IMEMR
Asunto principal:
Protocolos de Quimioterapia Combinada Antineoplásica
/
Tasa de Supervivencia
/
Resultado del Tratamiento
/
Linfoma Relacionado con SIDA
/
Terapia Antirretroviral Altamente Activa
Tipo de estudio:
Prognostic_studies
Límite:
Female
/
Humans
Idioma:
En
Revista:
Hematol. Oncol. Stem Cell Ther.
Año:
2011